Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

Newsweek has contacted Moderna and the HHS via email outside of regular office hours. Avian influenza A (H5N1) has caused at least 67 human illnesses, and was associated with one death ...

such as avian influenza A(H5N1). The company plans to design up to four new pandemic influenza vaccines and test them in ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving ...